Definitive Contract 75A50122C00008

Award Date 11/29/21
Potential Completion Date 11/28/25
Potential Value $54M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This purchase order, valued at $6.96 million, was awarded by the Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response to Monogram Biosciences, Inc. to establish high-throughput SARS-CoV-2 neutralizing antibody immunoassay capability and test human serum samples. As a subsidiary of Laboratory Corporation of America Holdings, Monogram will perform this work establishing a testing capability and analyzing samples at its facility in South San...
This firm fixed-price contract was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response to Monogram Biosciences, Inc., a for-profit subsidiary of Laboratory Corporation of America Holdings. The $9,109,520.00 contract requires Monogram Biosciences to provide rapid screening and testing services to evaluate the efficacy of medical countermeasures against SARS-CoV-2 pseudoviruses, including emerging variants. The base period...
This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Monogram Biosciences, Inc. for $17,665.00. The contract is for the PHENOSENSE HIV NEUT AB ASSAY, which provides testing and research services. Monogram Biosciences is a for-profit subsidiary of Laboratory Corporation of America Holdings that operates a laboratory in California. This award was not set aside for any...
The U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response, awarded a $508,865.04 firm-fixed price contract to the J. David Gladstone Institutes, a non-profit biomedical research organization in San Francisco, California. The contract is for research and development to multiplex CRISPR-Cas13A technology for an at-home viral diagnostic, in support of the agency's efforts to enable home-based diagnostics for SARS-CoV-2 acute infection. This...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $14.7 million firm fixed price definitive contract to Laboratories Nexelis Canada Inc., doing business as Pairimmune, to provide high throughput SARS-CoV-2 binding antibody immunoassay testing of clinical samples from COVID-19 vaccine trials. The contract supports assay development and validation for emerging SARS-CoV-2 variants. Per the solicitation, the one-year base period...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $10.9 million firm fixed price purchase order to The Broad Institute, Inc. for serology and virus neutralization testing in support of coronavirus COVID-19 response efforts. Performance will take place at the prime contractor's Cambridge, Massachusetts location through September 2021. No subcontractors or set aside designations were indicated. This award utilizes the prime...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $683,500 firm fixed price definitive contract to Luminex Corporation of Austin, Texas. The contract is for the delivery of Luminex's XMAP SARS-CoV-2 Multi-Antigen Antibody Typing Assay to support the agency's coronavirus COVID-19 response efforts. No set aside designation or major subcontractors were indicated. Luminex will provide its assay from September 2020 through July...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Genscript USA Inc., a for-profit biotechnology company, to provide antibody efficiency testing services. The $119,213.05 contract has a completion date of September 30, 2022 and does not utilize a set-aside designation. Genscript previously held a $1.5 million blanket purchase agreement with the U.S. Department of...
Hologic, Inc. was awarded a $6 million firm fixed price purchase order by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to expand production capacity for the Panther Fusion SARS-CoV-2 assay. The contract will support the agency's COVID-19 response efforts through increased domestic manufacturing of molecular diagnostic tests to detect the virus that causes coronavirus disease 2019. Performance will occur at Hologic's facility in San...
Battelle Memorial Institute, doing business as Battelle Anniston Operations, has been awarded a firm fixed price purchase order valued at $7.6 million by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. The purpose of this contract is to establish high-throughput SARS-CoV-2 neutralizing antibody immunoassay capability and testing of human serum samples in support of COVID-19 response efforts. Key subcontracts include those for fetal...

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $53.6 million definitive contract to Monogram Biosciences, Inc. to provide high throughput SARS-CoV-2 neutralizing antibody immunoassays for qualifying variants and testing of human serum samples. The contract is a firm fixed price agreement that will be performed by Monogram Biosciences, Inc. in South San Francisco, California over a four year period from November 2021 through November 2025.

Generated 11/27/23, 3:09 PM